![Sten Randahl Sörensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sten Randahl Sörensen
Chief Executive Officer at
CERENO SCIENTIFIC AB
Net worth: 686 127 $ as of 2026-05-30
Profile
Sten Randahl Sörensen is currently Chief Executive Officer & Director at Cereno Scientific AB since 2015, Chairman at SARomics Biostructures AB since 2013, and Director at SynAct Pharma AB since 2024.
Former positions include Chairman at AcuCort AB, Chairman at Stayble Therapeutics AB, Director-Secondary Prevention Products Marketing at AstraZeneca AB, and Head-International Marketing Operations at Monsanto Crop Sciences Sweden AB from 1987 to 1995.
Education includes undergraduate studies at the University of Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-12-30 | 1,128,514 ( 0.36% ) | 653 285 $ | 2026-05-30 | |
SYNACT PHARMA AB 0.03% | 2024-12-30 | 17,407 ( 0.03% ) | 32 841 $ | 2026-05-30 |
Sten Randahl Sörensen active positions
| Companies | Position | Start |
|---|---|---|
| CERENO SCIENTIFIC AB | Chief Executive Officer | 2015-08-31 |
| SYNACT PHARMA AB | Director/Board Member | 2024-03-19 |
SARomics Biostructures AB
 SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Chairman | 2012-12-31 |
Former positions of Sten Randahl Sörensen
| Companies | Position | End |
|---|---|---|
Monsanto Crop Sciences Sweden AB | Sales & Marketing | 1994-12-31 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Sales & Marketing | - |
| STAYBLE THERAPEUTICS AB | Chairman | - |
| ACUCORT AB | Chairman | - |
Training of Sten Randahl Sörensen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monsanto Crop Sciences Sweden AB | |
AcuCort AB
 AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
SynAct Pharma AB
 SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Health Technology |
Cereno Scientific AB
 Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Stayble Therapeutics AB
 Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
- Stock Market
- Insiders
- Sten Randahl Sörensen
